TSMC Approves Record $45B Capex, $30B Capital Injection, and Strong 2025 Financials
TSM has more than doubled off its 52-week low of $134.25.
Summary
TSMC's Board approved a massive capital expenditure plan of nearly $45 billion for capacity expansion, a $30 billion capital injection for hedging, and reported robust full-year 2025 financial results, signaling aggressive growth and financial strength.
Key Events · Financing and Capital Events · TSM
-
Record Capital Appropriations Approved
The Board approved approximately US$44.96 billion in capital appropriations for advanced technology, packaging, and fab expansion, indicating significant future growth and investment.
-
Substantial Capital Injection for Hedging
Authorized a capital injection of up to US$30 billion to TSMC Global Ltd. to reduce foreign exchange hedging costs, enhancing financial efficiency.
-
Strong Full-Year 2025 Financials Reported
Approved the 2025 Business Report and Financial Statements, reporting consolidated revenue of NT$3,809.05 billion and net income of NT$1,717.88 billion, with diluted EPS of NT$66.25.
-
Cash Dividend Declared
Approved a NT$6.0 per share cash dividend for the fourth quarter of 2025, with an ex-dividend date of June 11, 2026.
Analysis · TSM · Manufacturing
This 6-K filing from TSMC is highly significant, outlining aggressive strategic investments and strong financial performance. The approval of nearly $45 billion in capital appropriations for capacity expansion underscores the company's confidence in sustained demand for its advanced semiconductor technologies and its commitment to maintaining market leadership. This massive investment, representing approximately 3% of its market capitalization, signals a robust growth outlook. Furthermore, the $30 billion capital injection for foreign exchange hedging costs highlights a proactive approach to financial risk management and efficiency. The reported full-year 2025 financials confirm the company's strong operational execution, with substantial revenue and net income. The combination of these factors, especially with the stock trading near its 52-week high, reinforces a very positive investment thesis for TSMC, indicating continued expansion and financial optimization.
At the time of this filing, TSM was trading at $366.39 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.5T. The 52-week trading range was $134.25 to $359.60. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.